Prominent pharmaceutical executives resigned.

Following the wave of departures in the first half of the year, the second half of the pharmaceutical company's executive adjustment continues.
1. National Medicine: Vice Chairman resigns July 31, The State Pharmaceutical Company unanimously issued a notice that the company's board of directors recently received the company's vice chairman Ma Zhanjun submitted a written resignation report, because of the statutory retirement age, Ma Zhanjun no longer serves as the company's eighth board of directors vice-chairman, director.

as of the announcement date, Ma Zhanjun did not hold shares in the company 2.Xintian Pharmaceuticals: Deputy General Manager, Secretary of the Board of Directors resigned July 30, Guiyang Xintian Pharmaceuticals issued a notice that Yuan Liping for personal reasons, the application to resign the company's deputy general manager, the board secretary.
In accordance with the relevant provisions, Yuan Liping's resignation report shall take effect from the date of service to the board of directors.
Yuan Liping will no longer hold any positionin in the company after his resignation.
. Fangsheng Pharmaceuticals: Deputy General Manager Resigns July 29, Fangsheng Pharmaceuticals announced that Zhou Weien for personal reasons to apply to resign the Company's Deputy General Manager and all positions held by its subsidiaries in the company, the resignation report shall take effect from the date of service to the Company's Board of Directors.
Mr. Zhou's resignation, he will no longer hold any positionin at the company.
4. Hengrui Pharmaceuticals: Several Deputy General Managers Resign July 24, Hengrui Pharmaceuticals announced that Jiang Xinhua, Sun Hui, Liu Ji, Li Kejian due to age reasons to apply to resign from the company's deputy general manager, the resignation report from the date of service to the company's board of directors. After
resigned from the above-mentioned positions, Jiang Xinhua, Sun Hui and Liu Jie were still working for the company.
. Guangji Pharmaceuticals: The company's deputy general manager, the chairman of the supervisory board resigned On July 23, Guangji Pharmaceuticals issued two consecutive personnel changes announcement: Zhai Zhongyi due to job changes, applied to resign as the company's deputy general manager, resigned will continue to serve in the company, his resignation from the resignation report to the company's board of directors when effective.
Wang Shukun applied to resign as chairman and supervisor of the company's 9th Supervisory Board because of work needs.
resigns, he will not hold other positions with the company.
Wang Shukun's resignation application will take effect after the election of a new supervisor at the company's general meeting of shareholders.
during this period, Wang Shukun continued to perform the duties of the company's supervisor and chairman of the supervisory board.
6. Gan Li Pharmaceuticals: General Manager and Deputy General Manager resigned On July 20, Gan Li Pharmaceuticals announced that Gan Zhongru, Wang Damei and Ning Junjun respectively applied to resign as general manager, deputy general manager and finance director for personal reasons.
the above resignation report shall take effect from the time it is served on the Board of Directors of the Company. After
resigned, Gan Zhongru remained chairman of the company, chairman of the Strategy Committee, member of the remuneration and appraisal committee, Wang Damei still served as a director of the company, Ning Junjun is still engaged in financial management in the company's finance department.
GanZhongru and Wang Damei will lead the research and development team to the company's new product development and technological innovation work after resigning as senior managers.
. Hyundai Pharmaceuticals: President Resigns July 15, Shanghai Hyundai Pharmaceuticals announced that Yang Jun resigned as director and president of the company for work reasons, after his resignation, Yang Jun will not hold any positions in the company.
Hyundai Pharmaceuticals said that the company will complete the election of new directors and the appointment of the president as soon as possible in accordance with the relevant provisions, during which time, the company's chairman Zhou Bin acting as president.
8. Huahai Pharmaceuticals: Vice President Resigns July 3, Huahai Pharmaceuticals announced that Zhang Jiaai applied to resign as vice president of the company for personal reasons, the resignation report from the date of service to the company's board of directors, Zhang Jiaai resigned from any position in the company.
9. Red Day Pharmaceuticals: The company's deputy general manager resigned On July 2, Red Day Pharmaceuticals announced that, due to job adjustment, QIAN XIAOLUN applied to resign as the company's deputy general manager, he resigned from the above position sits still working in the company.
in accordance with the relevant regulations, Mr. QIAN XIAOLUN's resignation report shall take effect from the date of service to the Board of Directors of the Company.
under the influence of the new crown outbreak, band procurement and other factors, so far this year, the departure of pharmaceutical companies' executives can be described as intensive.
according to previous statistics, in the first half of this year, in 2019 alone, the revenue of more than 100 million yuan of listed pharmaceutical companies, there are 68 pharmaceutical companies in the executive level of the adjustment - involving China Pharmaceuticals, Fosun Pharma, Renfu Pharmaceuticals, Haizheng Pharmaceuticals, Ha Pharmaceuticals shares, China Resources Shuanghe and other well-known pharmaceutical companies.
with the advance of the third batch of volume procurement and the normalization of national organization drug collection, biological products, traditional Chinese medicine, etc. are facing the pressure of collection, and the medical insurance catalogue, base drug catalog also entered the normal adjustment stage.
can be said that in the policy intensive introduction, the market changes, pharmaceutical enterprises also need to adapt to the personnel changes to adapt to drastic changes.
in the long-term industrial upgrading, concentration of the background, pharmaceutical enterprises, pharmaceutical practitioners are facing a round of inevitable survival of the fittest journey.
.